Method of using HIV protease inhibiting compounds
    1.
    发明申请
    Method of using HIV protease inhibiting compounds 审中-公开
    使用HIV蛋白酶抑制化合物的方法

    公开(公告)号:US20030082207A1

    公开(公告)日:2003-05-01

    申请号:US10301638

    申请日:2002-11-22

    CPC分类号: A61K31/427 A61K31/4725

    摘要: In accordance with the invention, there is provided a method for preventing or treating a disease associated with abnormal cell proliferation, or for modulating or controlling apoptosis, wherein the method comprises administering to a patient in need of such treatment an effective amount of at least one human immunodeficiency virus (HIV) protease inhibiting compound, in particular ritonavir, saquinavir, or one of their pharmaceutically acceptable salts, in combination with a pharmaceutically acceptable vehicle. The method will thus be especially useful in treating diseases resulting from abnormal cell proliferation such as cancer.

    摘要翻译: 根据本发明,提供了一种预防或治疗与异常细胞增殖或调节或控制凋亡有关的疾病的方法,其中所述方法包括向需要这种治疗的患者施用有效量的至少一种 人体免疫缺陷病毒(HIV)蛋白酶抑制化合物,特别是利托那韦,沙奎那韦或其药学上可接受的盐之一,与药学上可接受的载体组合。 因此,该方法在治疗由异常细胞增殖如癌症引起的疾病中尤其有用。

    METHOD FOR TREATING COGNITIVE DYSFUNCTION
    2.
    发明申请
    METHOD FOR TREATING COGNITIVE DYSFUNCTION 失效
    治疗认知功能障碍的方法

    公开(公告)号:US20020177590A1

    公开(公告)日:2002-11-28

    申请号:US08952918

    申请日:1997-11-25

    IPC分类号: A61K031/55 A01N043/62

    摘要: The invention provides a method for treating a cognitive dysfunction comprising administering an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thienonull2,3-bnullnull1,5nullbenzodiazepine.

    摘要翻译: 本发明提供了一种治疗认知功能障碍的方法,包括给予有效量的2-甲基-4-(4-甲基-1-哌嗪基)-10H-噻吩并[2,3-b] [1,5]苯并二氮杂。

    Fluorine-containing cyclic esters, fluorine-containing cyclic alcohols, and their production processes
    3.
    发明申请
    Fluorine-containing cyclic esters, fluorine-containing cyclic alcohols, and their production processes 失效
    含氟环状酯,含氟环状醇及其制造方法

    公开(公告)号:US20040180954A1

    公开(公告)日:2004-09-16

    申请号:US10787964

    申请日:2004-02-27

    摘要: A fluorine-containing cyclic ester is represented by the formula 1: 1 wherein each R1 independently represents nullH or nullF, wherein R2 is one selected from the group consisting of nullH, nullF, nullCF3, nullOH, nullCOOH and nullCOOR4, where R4 is an alkyl group having a carbon atom number of 1-15, and wherein R3 is a substituent selected from the group consisting of nullF, nullCF3, and nullR5C(CF3)2OR6, where R5 is one selected from the group consisting of CH2, C2H4, and OCH2, and R6 is H or an acid-labile protecting group.

    摘要翻译: 含氟环酯由式1表示:其中每个R 1独立地表示-H或-F,其中R 2是选自-H,-F,-CF 3, - OH,-COOH和-COOR 4,其中R 4是碳原子数为1-15的烷基,其中R 3是选自-F,-CF 3的取代基 ,和-R 5 C(CF 3)2OR 6,其中R 5选自CH 2,C 2 H 4和OCH 2,R 6是H或酸不稳定保护基 。

    Compounds for cancer imaging and therapy
    7.
    发明申请
    Compounds for cancer imaging and therapy 失效
    用于癌症成像和治疗的化合物

    公开(公告)号:US20010006619A1

    公开(公告)日:2001-07-05

    申请号:US09755366

    申请日:2001-01-05

    摘要: The present invention relates to a class of compounds having affinity for certain cancer cells, e.g. lung carcinomas, colon carcinomas, renal carcinomas, prostate carcinomas, breast carcinomas, malignant melanomas, gliomas, neuroblastomas and pheochromocytomas. The compounds of the present invention can also bind with high specificity to cell surface sigma receptors and can therefore be used for diagnostic imaging of any tissue having an abundance of cells with sigma receptors. The present invention provides such compounds as agents for diagnostic imaging and for detecting and treating tumors containing the cancer cells described above.

    摘要翻译: 本发明涉及对某些癌细胞具有亲和力的一类化合物,例如, 肺癌,结肠癌,肾癌,前列腺癌,乳腺癌,恶性黑素瘤,神经胶质瘤,成神经细胞瘤和嗜铬细胞瘤。 本发明的化合物也可以以高特异性结合细胞表面σ受体,因此可用于具有西格玛受体细胞丰度的任何组织的诊断成像。 本发明提供了用于诊断成像和用于检测和治疗含有上述癌细胞的肿瘤的化合物。